Trademarkia Logo

Canada

C$
Trademark Search in Canada
2SEVENTYBIO

View On IC.GC.CA

2SEVENTYBIO
REGISTERED

on 21 Jun 2024

Last Applicant/ Owned by

2SEVENTY BIO INC.

60 Binney StreetCambridge MA 02142

US

Serial Number

2176306 filed on 31st Jan 2022

Registration Number

TMA1239641 registered on 21st Jun 2024

Registration expiry Date

31st Jan 2032

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

2SEVENTYBIO

Trademark usage description

pharmaceutical preparations and substances for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases Read More

Vienna Information

24 . 15 . 21

Arrowheads -- Note: Not including arrowheads in the form of angles (26.3.23).Pointes de flèches -- Note: Non compris les pointes de flèches en forme d'angles (26.3.23).

25 . 5 . 3

Backgrounds divided into two, diagonallyFonds partagés en deux en oblique

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

26 . 11 . 1

One line or one bandUne ligne ou une bande

27 . 7 . 1

Numerals presenting a special form of writingChiffres présentant un graphisme spécial

27 . 7 . 11

Numerals juxtaposed or joined to a letter or a figurative elementChiffres juxtaposés ou accolés à une lettre ou à un élément figuratif

Classification Information

Class [005]
Pharmaceutical preparations and substances for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases namely, respiratory infections, blood infections, skin infections, urinary tract infections, bowel infections, and eye infections, autoimmune diseases, and cancer; genetically modified cells namely, pharmaceutical preparations for use in cell therapy, biological preparations made from human blood cells for the treatment of cancer, and biological preparations made from human blood cells for use in T-cell immunotherapy, reagents for DNA editing and modification, and viral vectors, namely retroviral vectors, lentiviral vectors, adenoviral vectors, and adeno-associated viral vectors, for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases namely, respiratory infections, blood infections, skin infections, urinary tract infections, bowel infections, and eye infections, autoimmune diseases, and cancer

Classification kind code

11

Class [042]
Pharmaceutical research and development.

Classification kind code

11

Mark Details

Serial Number

2176306

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 20th Jul 2023		Search Recorded
Submitted for opposition 20
on 20th Jul 2023		Examiner's First Report
Submitted for opposition 223
on 20th Jul 2023		Total Provisional Refusal
Submitted for opposition 256
on 31st Jan 2023		Notification of Possible Opposition Sent
Submitted for opposition 48
on 11th Apr 2022		Agent Changed
Submitted for opposition 257
on 31st Mar 2022		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 30th Mar 2022		Created
Submitted for opposition 31
on 30th Mar 2022		Formalized
Submitted for opposition 30
on 31st Jan 2022		Filed
Submitted for opposition 228
on 31st Jan 2022		International Registration